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The primary objective of this study was to compare antimicrobial resistance 
patterns of Salmonella enterica with Escherichia coli isolated from the same dairy calves. 
Fecal samples were collected from February 2004 to September 2005 from 74 calves. 
Calves with at least one Salmonella isolate and one E.coli isolate were included in our 
analysis. The 148 isolates collected from the 74 calves were tested using a broth tube 
dilution method for determining resistance to several antimicrobial agents (n=14): AMP, 
APR, CEF, CHL, ENR, FLO, GEN, NEO, OXY, SPE, SCH, SDI, STH, and TRI. 
Considering resistance to individual drugs, the percent of E.coli isolates with resistance 
was over 50 for 11 drugs and the percent of Salmonella isolates resistant was over 50 for 
9 drugs. From the antimicrobial resistance patterns generated for E.coli (n=42) and 
Salmonella (n= 22), the bacteria were found to have 6 identical patterns in common. 
From these 6 patterns the most common pattern showed resistance to AMP, CEF, CHL, 
FLO, NEO, OXY, SCH, SDI, and STH. The association of antimicrobial resistance 
between Salmonella and E.coli for the same calves for individual antimicrobial agents 
proved not statistically significant. This study showed that resistance to drug classes 
important in human and animal medicine was common in Salmonella and E.coli from 
clinically ill calves. Overall, E.coli isolates were more resistant than Salmonella. While 
there were shared patterns of resistance (n=6) between Salmonella and E.coli, Salmonella 
isolates were not significantly more likely to be resistant to individual antibiotics if a calf 
had a resistant E.coli. Results suggest that selection pressure from recent exposure to 
drugs or interspecific gene transfer was not resulting in a strong association of resistance 
between the bacteria.  
 ACKNOWLEDGEMENTS 
 
I wish to express my gratitude to my research advisors, Dr. Lorin Warnick in the 
Department of Population Medicine and Diagnostic Sciences at Cornell University’s 
College of Veterinary Medicine and Dr. Bruce Currie in the Department of Animal 
Science, for their contributions and guidance this past year in helping me to produce this 
thesis.  
I am indebted to Dr. Kimberly Ray, Karen James, Dr. Kevin Cummings, and Julie 
Siler for all their hard work in teaching me correct research techniques. I especially want 
to thank Kim and Karen for their invaluable patience and teaching skills.  
I would also like to thank Dr. Charles Fossler, Dr. Chris Cripps and all the 
professional farmers, veterinarians, and project personnel for their hard work, technical 
expertise, and contribution to the field study, which generated the data, making this thesis 
possible.  
I would especially like to thank my parents and my sister for their decades of 
love, help, and unconditional support. To my parents, I am grateful for you instilling in 
me from an early age a sense of work ethic and determination, without which I most 
certainly would not be graduating from Cornell and attending veterinary school. For that, 
I am truly grateful. Finally, to Barrett, who kept me sane and grounded during this project 
and who has over four years shown me that life is not worth it if you take it too seriously!TABLE OF CONTENTS 
 
ABBREVIATIONS i 
CRITICAL TERMS  ii 
INTRODUCTION 1 
REVIEW OF LITERATURE  2 
Bacteria 2 
Antimicrobial Resistance  3 
Economic and Medical Concern  5 
Detection of Resistance  7 
Surveillance Programs  10 
Salmonella 11 
Escherichia coli 13 
MATERIALS and METHODS  15 
Recruitment and Herd Selection  15 
Collection of Samples  15 
Processing of Samples  16 
Classifying Antimicrobial Resistance  18 
Calf Samples  20 
Data Analysis  20 
RESULTS 21 
DISCUSSION 28 
CONCLUSION/CLINCAL RELEVANCE  30 
LITERATURE CITED  31 
APPENDICES 35 
   i
ABBREVIATIONS
 
AHI  Animal Health Institute  
AMP Ampicillan 
APR Apramycin 
CDC  Center for Disease Control and Prevention  
CEF Ceftiofur 
CHL Chloramphenicol 
CIPARS Canadian  Integrated Program for Antimicrobial Resistance Surveillance 
Europe  
CLSI  Clinical Laboratory Standards Institute  
DANMAP  Danish Integrated Antimicrobial Resistance Monitoring and Research 
Program  
EARSS  European Antimicrobial Resistance Surveillance System 
ENR Enrofloxacin   
FLO Florfenicol 
GEN Gentamicin   
MDR Multi-drug  Resistant 
NARMS  National Antimicrobial Resistance Monitory System 
NEO Neomycin 
OXY Oxytetracycline 
PFGE  Pulsed-Field Gel Electrophoresis  
SCH Sulfachloropyridazine 
SDI Sulfadimethoxine 
SPE Spectinomycin 
STH Sulphathiazole 
SVARM  National Veterinary Institute of Sweden 
TRI Trimethoprim/Sulfamethoxazole 
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CRITICAL TERMS 
 
Antibiotics  
Drugs produced by a microorganism that inhibit growth or destroy 
microorganisms. Antibiotics are used to treat infectious disease in humans, 
animals, or plants. 
Antimicrobial 
“Agent that destroys or inhibits microorganisms; capable of destroying or 
inhibiting their growth” (CLSI). Antibiotics are a type of antimicrobial. 
Antimicrobial Resistance 
Ability of a microorganism to multiply under conditions that would inhibit other 
members of the strain (Anonymous, 2006). Refers to failure of a given 
antimicrobial treatment.  
Breakpoint 
“(interpretive criteria) MIC or zone diameter value used to indicate susceptible, 
intermediate, and resistant as defined by the interpretive criteria used in CLSI 
documents M2—Performance Standards for Antimicrobial Disk Susceptibility 
Tests; M7—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria 
That Grow Aerobically; and M11—Methods for Antimicrobial Susceptibility 
Testing of Anaerobic Bacteria” (CLSI). 
Multi-Drug Resistant (MDR) 
  For this study, MDR is defined as resistance to 5 or more antimicrobial agents.
NARMS 
“A collaboration among CDC, U.S. Food and Drug Administration (Center for 
Veterinary Medicine) and U.S. Department of Agriculture (Food Safety and 
Inspection Service and Agricultural Research Services). State health departments 
send Salmonella, Shigella, Campylobacter and E. coli O157:H7 isolates received 
at their public health laboratories to CDC for susceptibility testing. The number of 
participating states increased in 2001 to 27, and the population under surveillance 
increased to 63 percent of the U.S. residents” (CDC, 2002). 
Salmonellosis 
An illness that resulted from a Salmonella infection. Symptoms of clinically ill 
dairy cattle include diarrhea, bloody stool, fever, dehydration, 
anorexia/emaciation, rapid breathing, unusual or foul odor stool, sloughing of skin 
from extremities, and sudden death.   1
INTRODUCTION 
Recently, many strains of Escherichia coli have been found to be resistant to 
multiple, structurally unrelated antimicrobial classes. This high prevalence of multi-drug 
resistance could be a significant source of resistance for other bacteria that share the same 
environment, such as Salmonella. Salmonella is an important pathogen in both animal 
and human hosts. If new types of resistance begin to emerge, present forms of treatment 
may become ineffective resulting in more serious disease in humans and animals. The 
primary objective of this study was to compare antimicrobial resistance patterns of 
Salmonella enterica with Escherichia coli from clinically ill dairy calves.    2
REVIEW OF THE LITERATURE 
 
Bacteria 
Bacteria are an integral part of the world and are ubiquitous to every habitat on 
Earth, adapting readily to shifts in environmental parameters by means of a short 
generation period, from minutes to hours (American Academy of Microbiology, 2002). 
These adaptive capabilities, in fact, account for the ease with which microorganisms 
respond to culture conditions in the laboratory, which are often radically different from 
the natural habitat of the organism (Roszak and Colwell, 1987). Most of these 
microorganisms are harmless. Some are symbiotic and actually protect the host from 
even more harmful bacteria. However, the emergence of bacterial pathogens that are 
resistant to medically important antimicrobial drugs is recognized as a significant public 
health concern (Tragesser et al., 2006). 
In 1674, Anton van Leeuwenhoek, a Dutch scientist, was credited as being the 
first microbiologist when he discovered bacteria. In 1859, Louis Pasteur, the father of 
modern microbiology, picked up where Leeuwenhoek left off (Fleming, 1946). With the 
beginnings of microbiology, bacterial pathogens became apparent as the cause of some 
infectious diseases and were found to have the ability to quickly adapt to new antibiotics. 
By 1928, Scottish bacteriologist Alexander Fleming accidentally discovered the 
antimicrobial agent produced by Penicillin notatum, when it inhibited the growth of the 
bacteria Staphylococcus (Fleming, 1946). Fleming’s discovery won him a Nobel Prize in 
1945 and marked the first modern antibiotic. 
Antibiotics, compounds produced by microorganisms that either kill or inhibit the 
growth of bacteria (Fleming, 1946), have been critical in the fight against infections for   3
over fifty years. However, infections that were once cured by the introduction of an 
antibiotic are now more difficult to combat because of resistance. Antimicrobial 
resistance develops as a natural consequence of the bacterial population’s ability to adapt. 
Bacteria’s continued exposure to antibiotics has resulted in this inevitable resistance to 
individual and multiple antimicrobial agents in many types of bacteria. 
 
Antimicrobial Resistance  
As genetic material can be transferred between bacteria, there is every reason to 
suspect that any genes carrying resistance to antibiotics could also be transferred. 
Resistance, as defined by the Institute of Food Technology (IFT), is the “temporary or 
permanent ability of a microorganism and its progeny to remain viable and/ or multiply 
under conditions that would destroy or inhibit other members of the strain” (Anonymous, 
2006). By 1940, Abraham and Chain submitted a “letter to the editor” in Nature titled 
“An Enzyme from Bacteria [E.coli] Able to Destroy Penicillin” and warned that the 
misuse of penicillin could lead to the propagation of mutant strains that would be 
resistant to antibiotics (Abraham and Chain, 1940). By 1952, Lederberg and Lederberg, 
confirmed that bacteria could transfer resistance to other bacteria through genetic 
exchange (Lederberg and Lederberg, 1952) and resistance to penicillin had begun 
appearing in hospitals. Physicians’ treatment options, which decades prior were broad, 
began diminishing drastically. Although there is much debate on the matter, according to 
the CDC, the main cause for this resistance is due to the over-prescription and/ or misuse 
of antibiotics. The CDC advises the use of the “precautionary principle”; the use of 
antibiotics should be reduced to the minimum necessary.    4
If bacteria come into contact with, but are not killed by, an antibiotic, they may 
adapt their cell structure or metabolism to make themselves resistant to that antibiotic in 
the future. Exposures to antimicrobial agents provide bacteria with opportunities to 
acquire mechanisms of resistance by changing their cellular physiology and structure. 
Methods of acquiring resistance include genetic mutation, modification of existing 
genetic material, or acquisition of new genetic material. Once resistance is acquired, 
bacteria can share and exchange information by either vertical gene transfer to the 
bacteria’s progeny or by horizontal gene transfer to individual bacteria either by 
transduction, transformation, or conjugation. Transduction occurs when a virus or 
bacteriophage transfers its DNA between two bacteria; transformation occurs when parts 
of the DNA are taken up by bacteria from the external environment; and, conjugation 
requires direct cell-to-cell contact to transfer small pieces of DNA, called plasmids, into 
another cell. The development of resistance in one bacterial population may spread to 
other populations over time. 
Multiple uses of antimicrobial agents in medicine, production of food animals, 
and crop protection are some of the reasons for increasing resistance to those agents 
(American Academy of Microbiology, 2002).  Previous studies have shown that waste 
effluents from hospitals contain one of the highest levels of antibiotic-resistant bacteria 
(Grabow and Prozesky, 1973). Other sources can also be found in sewage waste from 
septic tanks, pharmaceutical production plants, receiving waters, crops, or near farms 
where antimicrobial agents are used extensively to promote growth or treat and prevent 
disease (American Academy of Microbiology, 2002). These interconnected ecosystems 
can lead to the emergence of antimicrobial resistance, which could be transferred back   5
into human and animal disease organisms. If new forms of resistance start to emerge, the 
decreasing effectiveness of present forms of treatment and inability to treat certain 
infections is a distinct possiblity.  
 
Economic and Medical Concern 
Every year over 17 million people die of infectious diseases worldwide (Twomey, 
2000). More than 70 percent of the bacteria that cause hospital-acquired infections are 
resistant to at least one of the antibiotics most commonly used to treat them and over 60 
percent of deaths are caused by bacteria that have become resistant to at least one 
antibiotic (Twomey, 2000). The cost to the health care system is enormous. It is 
estimated that resistant bacterial infections increase health care costs by $4 billion per 
year in the United States alone (American Academy of Microbiology, 2002). Resistant 
bacteria cause infections that are more difficult to treat, requiring drugs that are often less 
readily available, more expensive, and more toxic (American Academy of Microbiology, 
2002). Examples of clinically important microbes that are rapidly developing resistance 
to available antimicrobials include bacteria that cause pneumonia, ear infections, 
meningitis (e.g., Streptococcus pneumoniae), skin, bone, lung, and bloodstream 
infections (e.g., Staphylococcus aureus), urinary tract infections (e.g., Escherichia coli), 
foodborne infections (e.g., Salmonella), and infections transmitted in health care settings 
(e.g., enterococci and Klebsiella spp.) (Panlilio A.L. et al., 1992; Hofmann J., Cetron 
M.S., Farley M.M., et al., 1995; Glynn M.K., Bopp C., Dewitt W., et al., 1998; Martone 
W., 1998; CDC, 1999; Gupta K., Scholes D., Stamm W.E., 1999; Wiener J., Quinn J.P., 
Bradford P.A., et al., 1999). Nearly all strains of Staphylococcus aureus in the United   6
States have become resistant to penicillin and 17 percent of all enterococci isolates are 
vancomycin resistant (Twomey, July 2000). Every year, approximately 40,000 cases of 
Salmonella are reported in the United States and are showing high rates of antibiotic 
resistance. The CDC (1999) also estimates that approximately 11 percent of S. 
pneumoniae are resistant to third-generation cephalosporin antibiotics and are becoming 
resistant to the newer fluoroquinolones. Many strains are reportedly becoming multi-drug 
resistant (MDR).  
  It is not known how much human and agricultural use of antimicrobial drugs 
contribute to resistance. The most recent study by the Animal Health Institute (AHI) 
showed that approximately 24.9 million pounds of antibiotics were used in 1999 (of 
which 88.3 percent was for therapeutic use).  By 2004, the total usage had dropped to 
21.7 million pounds (of which 95 percent was for therapeutic use) (Animal Health 
Institute, 2000, 2002, 2005). (See Table 1; Figure 1).  
Table 1. 2000 - 2002 Animal Health Institute (AHI) Survey
1
Active Antibacterial Ingredients Sold by AHI Members 
   2000 2001  2002 
Antibiotic Class  (lbs) (lbs)  (lbs) 
Ionophores/Arsenicals* 9165043 7758492 9050782
Tetracyclines 6693834 7144523 6649567
Cephalosporins, macrolides, 
lincosamides, polypeoptides, 
strptogramins, and other minor 
classes of antibiotics** 
4857896 4268658 5056515
Sulfonamides and Penicillins  2363151 2406072 815298
Aminoglycosides 337819 257252 415219
Fluoroquinolones 38082 36204 33602
Total 23455825 21871201 22020983
* Unique drug products developed for animal production and not related to traditional 
antibiotics 
** Grouping necessary to abide by disclosure agreements 
                                                 
1 Source: (Animal Health Institute, 2002)   7
 
Figure 1. Volume of antibiotic usage in farm and companion animals 1999-2001.
2  
 
The survey, however, was composed of only AHI members and does not include all 
generic antibiotic manufacturers. Recent estimates of the amount of antibiotics used in 
production agriculture ranges from 18.4 million to 30 million pounds compared to the 
usage in human medicine, which ranges from 4.5 to 32.2 million pounds (Anonymous, 
2006). 
  Although its role in human health is still heavily debated, transfer of 
antimicrobial-resistant bacteria from food animals to humans has been documented 
(Sanchez S et al., 2002; Swartz M.N., 2002). Considerable concern exists over antibiotic 
usage in food animals for drugs classified as critical for human medicine (FDA, Center 
for Veterinary Medicine). Examples of these antimicrobial agents include 
fluoroquinolones, such as enrofloxacin, and expanded-spectrum cephalosporins, such as 
ceftiofur, a third-generation cephalosporin. 
 
Detection of Resistance 
Resistance among microorganisms can generally be detected either 
phenotypically or genotypically.  The phenotypic approach is the usual method when 
testing bacteria for clinical purposes. The Clinical Laboratory Standards Institute (CLSI) 
                                                 
2 Source: (Animal Health Institute, 2002)   8
has outlined standard susceptibility testing guidelines. Phenotypic-based antibiotic 
sensitivity tests most often evaluate resistance using growth inhibition, such as broth or 
agar disc diffusion assays.  
The agar disc diffusion, or Kirby-Bauer, method inoculates an agar plate 
uniformly with the test organism. A paper disk is impregnated with a fixed concentration 
of an antibiotic and then placed on the agar surface. Growth of the organism and 
diffusion of the antibiotic commence simultaneously resulting in a circular “zone of 
inhibition” in which the amount of antibiotic exceeds inhibitory concentrations. The 
diameter of the inhibition zone is a function of the amount of drug in the disk and 
susceptibility of the microorganism. Zone diameter can be then be correlated with 
susceptibility. Using the zone of inhibition’s diameter an organism can be classified as 
“susceptible”, “intermediate”, or “resistant” to an antibiotic based on the CLSI criteria. 
(See Figure 2). 
 
Figure 2. Agar disc diffusion method.
3
  The broth dilution method is the standard method in many laboratories for 
determining levels of resistance to antibiotics because it can be more easily automated. 
Serial dilutions of the antibiotic are made in a liquid medium, which are then inoculated 
with a standardized number of organisms and incubated at 35°C for 16-20 hours. The 
                                                 
3 Source: (Rollins, 2000)   9
lowest concentration (highest dilution) of antibiotic that prevents the appearance of 
turbidity is considered to be the minimal inhibitory concentration (MIC). As with the disk 
diffusion method, the results can then interpreted as “susceptible”, “intermediate”, or 
“resistant”.  
  These “breakpoints” (susceptible, intermediate, or resistant) are determined in 
part on the basis of achievable drug concentrations at the site of the infection 
(Anonymous, 2006). The CLSI has established breakpoints for many drugs and 
organisms. (See Table 2). Salmonella breakpoints for most drugs were extrapolated from 
human data for other Enterobacteriaceae. However, because there is no standard 
breakpoint for identifying resistance versus susceptibility to all clinically important 
antimicrobial agents, interpretation of the data can be problematic. 
   10
Table 2. Antimicrobial agents used in susceptibility testing against Salmonella and interpretive 
criteria of MIC results.
4
Interpretive Criteria of MIC (μg/mL)  AM Class  Antimicrobial Agent 
Susceptible Intermediate Resistant 
Source* 
Aminoglycosides Amikacin  ≤16 32  ≥64 CLSI 
 Gentamicin  ≤4 8  ≥16 CLSI 
 Kanamycin  ≤16 32  ≥64 CLSI 
 Neomycin  ≤8   ≥16 No  CLSI^# 
 Streptomycin  ≤32   ≥64 No  CLSI† 
Aminocyclitols Spectinomycin  ≤64   ≥128 No  CLSI# 
Beta-Lactams: 
Penicillins 
Amoxicillin/ Clavulanic 
Acid 
≤8/4 16/8  ≥32/16 CLSI 
 Ampicillin  ≤8 16  ≥32 CLSI 
Beta-Lactams: 
Cephalosporins 
(1
st Gen.) 
Cephalothin  ≤8 16  ≥32 CLSI 
Beta-Lactams: 
Cephalosporins 
(2
nd Gen.) 
Cefoxitin  ≤8 16  ≥32 CLSI 
Beta-Lactams: 
Cephalosporins 
(3
rd Gen.) 
Ceftiofur  ≤2 4  ≥8 No  CLSI† 
 Ceftriaxone  ≤8 16-32  ≥64 CLSI 
Phenicols Chloramphenicol  ≤8 16  ≥32 CLSI 
 Florfenicol  ≤8 16  ≥32 No  CLSI^ 
Fluoroquinolone Ciprofloxacin  ≤1 2  ≥4 CLSI 
 Enrofloxacin  ≤0.25   ≥0.5 No  CLSI^ 
Quinolone Nalidixic  Acid  ≤16   ≥32 CLSI 
Sulfonamide Sulphizoxazole  ≤256   ≥512 CLSI 
 Sulphachloropyridazine  ≤256   ≥512 No  CLSI‡ 
 Sulphadimethoxine  ≤256   ≥512 No  CLSI‡ 
 Sulphathiazole  ≤256   ≥512 No  CLSI‡ 
 Trimethoprim/ 
Sulphamethoxazole 
≤2/38   ≥4/76 CLSI 
Tetracycline Oxytetracycline  ≤4 8  ≥16 CLSI 
 Tetracycline ≤4 8  ≥16 CLSI 
* CLSI – Clinical Laboratory Standards Institute 
^ Breakpoint used in SVARM 2002 
# Breakpoint used in DANMAP 2002 
† Breakpoint used in NARMS Salmonella report 
‡ Breakpoint used from sulfizoxazole 
 
 
Surveillance Programs 
  Recently many countries established surveillance programs to monitor 
antimicrobial resistance. Currently in the United States, the National Antimicrobial 
                                                 
4 Source:(Ray, 2007)   11
Resistance Monitoring System for Enteric Bacteria (NARMS), established in 1996, is 
used as the principal organization for monitoring antibiotic resistance in enteric bacteria. 
NARMS is a collaboration among the CDC, U.S. Food and Drug Administration (Center 
for Veterinary Medicine) and U.S. Department of Agriculture (Food Safety and 
Inspection Service and Agricultural Research Services) (CDC, 2002). It monitors the 
changes among susceptibility patterns for two categories of enteric bacteria: (1) zoonotic 
bacterial pathogens (Salmonella and Campylobacter) and (2) usually non-pathogenic 
bacteria (E.coli and Enterococcus). The CDC collects isolate samples from state health 
departments and annual reports of the NARMS surveillance are available at websites 
from the CDC (human clinical cases) (NARMS, 2003b), FDA (retail meats) 
(HHS/FDA/CVM, 2003), and USDA (animals and animal products).  
Other international surveillance systems include Canada (Canadian Integrated 
Program for Antimicrobial Resistance Surveillance (CIPARS)), Europe (European 
Antimicrobial Resistance Surveillance System (EARSS)), Denmark (Danish Integrated 
Antimicrobial Resistance Monitoring and Research Program (DANMAP)), Norway 
(NORM, for human surveillance, and NORM-VET, for animal and food surveillance), 
and Sweden (National Veterinary Institute of Sweden (SVARM)).  
  
Salmonella  
Salmonella from the family Enterobacteriaceae are gram-negative, rod-shaped 
bacteria. Salmonella enterica sub-species enterica, which includes serotypes such as 
Typhimurium, Enteritidis, and Newport, are responsible for most Salmonella infections 
in humans and animals. Both clinical and sub-clinical infections may occur. The source   12
for the transmission of antimicrobial resistant Salmonella is of current interest because of 
the increase in the prevalence of resistant strains. 
In Humans 
  Clinical signs of salmonellosis in humans include an acute onset of fever, 
abdominal pain, diarrhea, nausea, sometimes vomiting, and on rare occasions life 
threatening dehydration (World Health Organization.). It has become one of the most 
widely distributed food-borne illnesses in the United States. Fluoroquinolones and third-
generation cephalosporins (given to children with serious infection) are important 
antimicrobial agents used for treating salmonellosis. Other drugs given as alternatives to 
the above treatment include chloramphenicol, ampicillin, amoxicillin, and trimethoprim-
sulfamethoxazole. Emerging resistance to these antimicrobials, specifically 
fluoroquinolones and third-generation cephalosporins, remain of great concern. 
In Dairy Cattle 
Clinical signs of Salmonella in dairy cattle include enteritis, fever, anorexia, 
depression, reduced milk yield, diarrhea, and, in rare cases, abortion (Ray, 2007). 
Salmonella most commonly causes illness in calves and adult cows and is usually passed 
from animal to animal by fecal-oral contact (See Figure  3).    13
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Figure 3. Fecal-oral transmission
5
Some cattle may harbor Salmonella in their gut and exhibit no symptoms. These 
“carriers” can shed Salmonella into the environment in their manure for extended periods 
of time without giving any indication of an infection. This can result in transmission of 
the disease to other animals and humans. It is therefore important to investigate 
antimicrobial resistance in Salmonella infected dairy cattle. A previous longitudinal study 
found that Salmonella was found on over 90 percent of a sample of dairy farms in the 
Midwest and Northeast United States over a one-year period (Fossler et al., 2005). 
 
Escherichia coli
Similar to Salmonella, Escherichia coli is a gram-negative, rod-shaped bacteria 
and is considered to be the most common bacterial organism in the world. Some strains 
are pathogenic and pose an increasing threat to the successful management
 of calf scours, 
while most are commensal bacteria that reside in the intestinal tracts of animals and 
humans without causing illness. In the past few years, many strains of E.coli have been 
                                                 
5 Source: http://babcock.cals.wisc.edu/dwt/en_transmission.pdf
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found to be resistant to multiple, structurally unrelated antimicrobial classes, including 
quinolones, expanded-spectrum cephalosporins, and aminoglycosides (Orden et al., 2001; 
Donaldson et al., 2006). The high prevalence
 of these multi-drug resistant E. coli in 
calves could
 be a significant source of resistance genes for other bacteria
 that share the 
same environment, such as Salmonella (Donaldson et al., 2006). 
   15
METHODS 
Recruitment and Herd Selection 
The design, herd enrollment, and provided isolates for this investigation were 
described in detail previously (Cripps et al., 2006; Ray, 2007). As reported earlier, 
between February 2004 and September 2005, veterinary practices from New York, 
Vermont, Pennsylvania, Massachusetts, and Connecticut were enrolled to investigate the 
incidence of clinical salmonellosis in dairy cattle in the northeastern United States. 
Veterinarians were asked to enroll farms for which they provided routine clinical services 
and that had at least 30 dairy cattle. Participating veterinarians enrolled client herds by 
submitting a one-page survey containing contact information, cattle numbers, housing 
type, salmonellosis herd history, and vaccination practices. Veterinarians were asked to 
educate their clients about the signs of bovine salmonellosis. Signs included rectal 
temperature over 103°F, dullness, depression, decreased feed intake, diarrhea containing 
blood, strands of mucous or intestinal lining, or having a foul odor. Clients were also 
asked to consider salmonellosis for cattle found dead after a brief period of being off feed 
in the absence of other specific clinical signs or when an unusual number of deaths 
occurred in cattle with diarrhea. Most herds were enrolled by September 30, 2004 
(90.7%; 754/831). The last herd was enrolled January 26, 2005. 
 
Collection of Samples 
Fecal samples were obtained from suspected cases and submitted to the Animal 
Health Diagnostic Center (AHDC) at Cornell University for Salmonella culturing. The 
cost of shipping and analysis of samples were covered by the study to encourage   16
sampling of all animals suspected of having salmonellosis. Calves and weaned heifers 
were also eligible for free laboratory testing of other enteric pathogens, such as 
Escherichia coli, if requested by the client or veterinarian. After the diagnosis of an initial 
salmonellosis case in a herd was established by bacteriological culture, owners and 
managers were allowed to make preliminary diagnoses of subsequent suspected cases and 
submit samples for culture under the supervision of their herd veterinarian.  
 
Processing of Samples 
For any cattle that exhibited signs of clinical salmonellosis, 5g of feces was 
collected from the cows’ rectum and put into 30 ml vials containing Cary-Blair transport 
medium (15ml). Within 24 hours, the samples were taken on ice to the Animal Health 
Diagnostic Center at Cornell University. 
Salmonella Isolation 
Standard culturing methods were used to isolate Salmonella. A swab was taken of 
the sample and enriched in 10ml of tetrathionate broth (TTB; Difco, Detroit, MI), which 
contained 0.2ml of iodine. The broth was incubated at 42°C for 18-24 hours. After 
incubation, the mixture was streaked onto two agars: Brilliant Green Novobiocin agar 
(BGN; BBL
TM, Becton Dickinson and Company, Franklin Lakes, NJ) and Xylose-Lysine-
Tergitol-4 agar (XLT-4) and incubated at 37°C for 18-24 hours. H2S-producing colonies 
(black) were expected on the XLT-4 plate and lactose-fermenting colonies (red) were 
expected on the BGN plate. If both black and red colonies appeared in both agars (XLT-4 
and BGN, respectively) the colonies were inserted in a Kligler’s iron agar (KIA; BBL
TM) 
slant. If no colonies appeared, the agars (BGN and XLT-4) were re-incubated for an   17
additional 18-24 hours. KIA slants were incubated at 37°C for 18-24 hours. If typical 
Salmonella characteristics such as acid butt, alkaline, slant, gas, and H2S were observed, 
then the samples were further tested for somatic serogroups, B, C1, C2, D1, and E. After 
slide agglutination with antisera, Sensititre Automated Microbiology System’s A80 panel 
(TREK Sensititre Microbiology System Division, Westlake, OH) identified positive 
Salmonella colonies. All positive colonies were sent to the National Veterinary Services 
Laboratory (NVSL), USDA, APHIS, VS, Ames Iowa for complete serotyping.  
Escherichia coli Isolation 
The Animal Health Diagnostic Center at Cornell University used standard 
isolation methods for culturing and identifying E.coli isolates. Samples were directly 
plated on Levine EMB agar plates and then incubated at 37°C for 18-24 hours. 
Characteristic colonies (purple center) were selected and confirmed as E.coli using 
Sensititre Automated Microbiology System’s panel (TREK Sensititre Microbiology 
System Division, Westlake, OH) for identification of gram negative bacteria. 
Antimicrobial Susceptibility Testing 
A broth microdilution method was used to determine the minimal inhibitory 
concentration (MIC) of all isolates using a standard panel of antimicrobial agents. Results 
from 14 of these were used for this study: ampicillin (AMP), apramycin (APR), ceftiofur 
(CEF), chlortetracycline (CHL), enrofloxacin (ENR), florfenicol (FLO), gentamicin 
(GEN), neomycin (NEO), oxytetracycline (OXY), spectinomycin (SPE), 
sulphachloropyridazine (SCH), sulphadimethoxine (SDI), sulphathiazole (STH), and 
trimethoprim/sulfamethoxazole (TRI). Most isolates were tested for antimicrobial 
susceptibility within a week of isolation; however a few isolates were recovered for MIC   18
testing after approximately one year of storage. Isolates stored on TSA slants were 
recovered for antimicrobial susceptibility testing by a sub-culture within 24 hours on 
TSA with 5 percent sheep blood (BAP). Lyophilized isolates were recovered for 
antimicrobial susceptibility testing by reconstitution in water followed by an overnight 
sub-culture on BAP. The MIC of Salmonella and E.coli isolates were determined using 
the Sensititre semi-automated antimicrobial susceptibility testing system (Trek 
Diagnostic Systems, Cleveland, OH). For each antimicrobial agent, the minimum dilution 
that inhibited growth of the Salmonella isolate was recorded as the MIC. Clindamycin, 
macrolides, natural penicillins, and tiamulin have poor activity against Salmonella so 
clindamycin, erythromycin, tilmicosin, tylosin, penicillin, and tiamulin were excluded 
from this analysis (Plumb, 2002). The 8 antimicrobial classes represented by drugs 
included in the current analysis were aminoglycosides, aminocyclitols, penicillins, 
cephalosporins, phenicols, fluorquinolones, sulfonamides, and tetracyclines. Quality 
control was performed every week while the antimicrobial susceptibility testing was 
conducted using the following four bacteria: Escherichia coli ATCC 25022, 
Staphylococcus aureus 29213, Enterococcus faecalis 29212, and Pseudomonas 
aeruginosa 27853. Clinical and Laboratory Standards Institute (CLSI) ranges for quality 
control were used when available (CLSI, 2006a, 2006b). Quality control results were 
always within expected ranges.  
 
Classifying Antimicrobial Resistance 
CLSI interpretive criteria were used to classify Salmonella and E.coli isolates as 
resistant or not resistant to individual antimicrobial agents based on MIC panel results   19
(NCCLS, 2002a, 2002b). CLSI resistant breakpoints were based on human data for 
Enterobacteriaceae. The resistant breakpoints presented in the National Antimicrobial 
Resistant Monitoring System (NARMS) 2000 Annual Report were used for neomycin, 
spectinomycin, ceftiofur, florfenicol, enrofloxacin, sulphachloropyridazine, 
sulphadimethoxine, and sulphathiazole since no interpretive criteria for 
Enterobacteriaceae were available for these antimicrobial agents (U.S. Department of 
Agriculture, 2000). CLSI resistant breakpoints for sulfizoxazole were used for 
sulphachloropyridazine, sulphadimethoxine, and sulphathiazole (See Table 3). 
Table 3. Antimicrobial agents used to determine the MIC of Salmonella and E.coli isolates from 
cattle exhibiting clinical signs of salmonellosis. 
Interpretive Criteria of MIC (μg/mL)  AM Class  Antimicrobial Agent 
Susceptible Intermediate Resistant 
Source* 
Aminoglycosides Gentamicin 
(GEN) ≤4 8  ≥16 CLSI 
 Neomycin 
(NEO) ≤8   ≥16 No  CLSI^# 
Aminocyclitols Apramycin 
(APR) ≤8 16-32  ≥32 No  CLSI† 
 Spectinomycin 
(SPE) ≥8   ≥128 No  CLSI# 
Beta-Lactams: 
Penicillins 
Ampicillin 
(AMP) ≤8 16  ≥32 CLSI 
Beta-Lactams: 
Cephalosporins 
(3
rd Gen.) 
Ceftiofur 
(CEF) ≤2 4  ≥8 No  CLSI† 
Phenicols Chloramphenicol 
(CHL) ≤8 16  ≥32 CLSI 
 Florfenicol 
(FLO) ≤8 16  ≥32 No  CLSI^ 
Fluoroquinolone Enrofloxacin 
(ENR) ≤0.25   ≥0.5 No  CLSI^ 
Sulfonamide Sulphachloropyridazine 
(SCH) ≤256   ≥512 No  CLSI‡ 
 Sulphadimethoxine 
(SDI) ≤256   ≥512 No  CLSI‡ 
 Sulphathiazole 
(STH) ≤256   ≥512 No  CLSI‡ 
 Trimethoprim/ 
Sulphamethoxazole 
(TRI)
≤2/38   ≥4/76 CLSI 
Tetracycline Oxytetracycline 
(OXY) ≤4 8  ≥16 CLSI 
* CLSI – Clinical Laboratory Standards Institute 
^ Breakpoint used in SVARM 2002 
# Breakpoint used in DANMAP 2002 
† Breakpoint used in NARMS Salmonella report 
‡ Breakpoint used from sulfizoxazole 
 
Samples classified as resistant to 5 or more antimicrobial agents were also classified as 
multi-drug resistant (MDR).  
   20
Calf Samples 
Only the calf samples that were tested for both Salmonella and Escherichia coli 
were used for this study (n=959). Calves with at least one Salmonella isolate and one 
E.coli isolate were included in our analysis (n=74). Resistance patterns (a series of 0’s 
and 1’s; with 0=susceptible and 1=resistant) for all 14 antimicrobial agents were 
generated for each calf to test for resistance similarity among Salmonella and E.coli. The 
associations between Salmonella resistance and E.coli resistance for individual 
antimicrobial agents and the association of MDR for the two bacterial species were 
determined using Fisher’s Exact tests. 
 
Data Analysis 
All results were stored in a Microsoft® Access (2000, Microsoft Corporation, 
Redmond, WA) database. Data was analyzed using Microsoft® Excel (2000, Microsoft 
Corporation, Redmond, WA). Statistical analysis was analyzed using Statistix 8 (2006, 
Analytical Software, Tallahassee, FL) software. Statistical tests with p<0.05 were 
considered significant.    21
RESULTS 
There were 831 dairy herds enrolled in the field study. Samples from 959 calves 
from 174 herds were used for this part of the investigation. Of the 959 samples, there 
were 148 isolates from calves with both bacterial types: 74 Salmonella and 74 E.coli 
isolates. Only calves with one Salmonella isolate and one E.coli isolate were included in 
our analysis. Most herds enrolled in the salmonellosis incidence study were from New 
York (n=632) and Vermont (n=146), but a few herds were also enrolled from 
Pennsylvania (n=40), Connecticut (n=8), and Massachusetts (n=5). Salmonella was not 
isolated from calves in Connecticut, Massachusetts, Vermont, and Pennsylvania. 
Therefore, all isolates included in this study were from herds in New York. Other 
management characteristics of the herds enrolled in the salmonellosis incidence study and 
calves with at least one Salmonella isolate and one E.coli isolate are presented in Table 4.   22
Table 4. Herd characteristics of herds enrolled in salmonellosis incidence study. 
 
Herds Enrolled in 
Salmonellosis Incidence 
Study 
Study 
Herds 
Number of Herds  831 74 
State    
New York  632  74 
Vermont 146  0 
Pennsylvania 40  0 
Connecticut 8  0 
Massachusetts 5  0 
Calf Housing    
Hutch 228  38 
Greenhouse 61  21 
Curtain Barn  42  6 
In Cow Barn  338  3 
Other 114  6 
No Calves  48  0 
Vaccinations    
Endovac-Bovi®
a 57 5 
J-vac® E.coli
 b 104 5 
J5 E.coli Bacterin
 c 190 62 
Autogenous Salmonella Bacterin 19  2 
Commercial Salmonella Bacterin 4  0 
None of the above  490  6 
a a vaccine that causes the immune system to make antibodies against Gram Negative bacterial 
endotoxins, such as E.coli, Salmonella, Pasteurella, and Moraxella bovis organisms. 
b for the vaccination of healthy cattle as an aid in prevention of mastitis due to E. coli and the effects of 
endotoxemia caused by E. coli and Salmonella typhimurium.
c reduces frequency and severity of coliform mastitis  
 
Of the 74 calves in this study, the percent of calves with multi-drug resistant 
(MDR) Salmonella was 68.9 percent (n=51) and with MDR E.coli was 90.5 percent 
(n=67).  (See Figure 4). Ninety-four percent (n=48) of the 51 MDR Salmonella isolates 
were also MDR E.coli while only 71.6 percent (n=48) of the MDR E.coli isolates (n=67) 
were also MDR Salmonella. There was a tendency for Salmonella to be more likely to 
show MDR if the calf had MDR E.coli, however, this association was not statistically 
significant (p=0.19). (See Appendix 2). 
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Figure 4. Frequency of resistance to antimicrobial agents among calves 
 
For individual antimicrobial agents, Salmonella isolates from this study exhibited a 
high level of antimicrobial resistance with more than 50 percent of isolates resistant to one or 
more of the following antimicrobial agents:  AMP, CEF, CHL, FLO, NEO, OXY, SCH, SDI, 
and STH.  In contrast, APR and ENR resistance was not found among any Salmonella isolates 
(See Table 3 for breakpoints). E.coli isolates also had more than 50 percent of isolates resistant 
to one or more of the following:  AMP, CEF, CHL, FLO, NEO, OXY, SPE, SCH, SDI, STH, 
TRI. (See Table 5).  For each antimicrobial assessed, with the exception of FLO and SCH, the 
percentage of resistant E.coli was higher than the percentage of resistant Salmonella sometimes 
increasing by 2 (e.g. SPE) or even 7 fold (e.g. TRI).   24
Table 5. Percent of calves with at least one Salmonella isolate and one E.coli isolate resistant to 
individual antimicrobial agents 
Antimicrobial 
Agent  Sample Size 
%  
Salmonella 
Resistance 
%  
E.coli 
Resistance 
AMP  74 67.6% 91.9%
APR  39 0.0% 2.6%
CEF  72 51.4% 52.8%
CHL  73 65.8% 97.3%
ENR  72 0.0% 1.4%
FLO  71 62.0% 54.9%
GEN  74 2.7% 21.6%
NEO  73 57.5% 90.4%
OXY  73 69.9% 97.3%
SPE  71 28.2% 70.4%
SCH  73 79.5% 74.0%
SDI  71 77.5% 90.1%
STH  71 71.8% 88.7%
TRI  74 8.1% 75.7%
 
There were 22 unique antimicrobial resistance patterns identified for Salmonella 
isolates and 42 unique antimicrobial resistance patterns identified for E.coli isolates. (See 
Table 6). There were 6 antimicrobial resistance patterns identified among both 
Salmonella and E.coli isolates. Pan-susceptibility was the most common individual 
resistance pattern observed in this study. Of the 6 unique antimicrobial resistance patterns 
shared by E.coli and Salmonella, 5 patterns were resistant to 7 or more antimicrobial 
agents, most commonly including AMP, CEF, CHL, FLO, NEO, OXY, SCH, SDI, STH. 
All the Salmonella and E.coli isolates shown in Table 7 were susceptible to APR, ENR, 
GEN. The most commonly observed resistance pattern for both Salmonella (n=8) and 
E.coli (n=3) was sequence number 4 (AMP-CEF-CHL-FLO-NEO-OXY-SCH-SDI-STH) 
(See Table 7).    25
Table 6. Antimicrobial resistance patterns for Salmonella (n=22) and E.coli (n=42) in dairy calves 
SALMONELLA   E.COLI
12345678901234
a Count   12345678901234
a Count 
0_000000001000 4  0_010000101000 1 
0_000000001100 4  0_010001101000 1 
00000000000000 15  00000000000000 1 
00010101101110 1  00010000110000 1 
1_000100111110 1  00010001101111 1 
1_010001111110 5  00010101101110 1 
1_010101101110 2  1__1__011_0__1 1 
1_010101111110 3  1__1__011_1__0 1 
1_100101101110 1  1_0_0_1______1 1 
1_110000101110 1  1_010001101111 1 
1_110001111111 1  1_010001111111 3 
1_110100101110 2  1_010011111111 3 
1_110101101110 8  1_110000101111 1 
1_110101101111 3  1_110001111111 1 
10000100111110 1  1_110100111111 1 
10010100111110 1  1_110101101110 3 
10110100101110 1  1_110101111110 1 
10110100111111 2  1_110101111111 8 
10110101100110 1  1_110111111111 3 
10110101101110 11  10000001000111  1 
10110101111110 4  10010000110001 1 
10110111111110 2  10010001100000 2 
Grand Total  74  10010001100110  1 
     10010001100111  1 
     10010001101111  3 
     10010001111111  6 
     10010101110111  1 
     10010101111111  2 
     10010111111111  1 
     10110011110110  1 
     10110011110111  1 
     10110101100110 2 
     10110101101111  1 
     10110101110101  1 
     10110101110110  1 
     10110101110111  2 
     10110101111110 1 
     10110101111111  5 
     10110110111111  1 
     10110111111111  3 
     10111111110111  1 
     11010011111111  1 
     Grand  Total  74 
a 1(AMP); 2(APR); 3(CEF); 4(CHL); 5(ENR); 6(FLO); 7(GEN);   
8(NEO); 9(OXY); 0(SPE); 1(SCH); 2(SDI); 3(STH); 4(TRI) 
0, Not Resistant; 1, Resistant; _, not tested   26
Table 7. Identical antimicrobial resistance patterns for both Salmonella and E.coli 
Seq 
#  12345678901234
a
Salmonella 
Isolates 
E.coli 
Isolates 
1  00000000000000 15 1 
2  00010101101110 1 1 
3  1_110001111111 1 1 
4  1_110101101110 8 3 
5  10110101100110 1 2 
6  10110101111110 4 1 
a 1(AMP); 2(APR); 3(CEF); 4(CHL); 5(ENR); 6(FLO); 7(GEN); 
8(NEO); 9(OXY); 0(SPE); 1(SCH); 2(SDI); 3(STH); 4(TRI) 
0, Not Resistant; 1, Resistant; _, not tested 
 
There was no obvious association of resistance patterns between Salmonella and E.coli 
isolated in the same calf (See Appendix 1).  
Fourteen antimicrobial agents were analyzed to observe whether there was an 
association of resistance of E.coli with resistance of Salmonella. The majority of the 
antimicrobial agents (n=8) were not significant at the 0.05 level. There was a significant 
association of antimicrobial resistance between Salmonella and E.coli for GEN and SPE, 
p=0.04 and p=0.05, respectively. (See Table 8 and Appendix 2). 
Table 8. Significance of antimicrobial resistance between Salmonella and E.coli for individual 
antimicrobial agents 
 P-value  Significant 
AMP  0.38 No 
APR  1.00 No 
CEF  0.24 No 
CHL  1.00 No 
ENR  1.00 No 
FLO  0.48 No 
GEN  0.04 Yes 
NEO  0.07 No 
OXY  1.00 No 
SPE  0.05 Yes 
SCH  1.00 No 
SDI  0.11 No 
STH  0.30 No 
TRI  0.33 No 
Ho, E.coli resistance has no significant influence on 
Salmonella resistance   27
Although there was no effect of calf age at the time of testing on the percentage of 
resistance for either Salmonella or E.coli, the percentage of MDR Salmonella always 
remained lower than that of MDR E.coli. (See Table 9, Figure 5). 
Table 9. Number of MDR calves as age increased 
Age (days) 
Total No. of 
calves 
Salmonella 
Isolates  
(%) 
E.coli 
Isolates 
(%) 
1-4  23  18 (78.3)  20 (87.0) 
5-10  29  17 (58.6)  27 (93.1) 
11-44  22  16 (72.7)  20 (90.9) 
Total:  74    
 
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
1-4 5-10 11-44
Age (days)
%
 
M
D
R
 
R
e
s
i
s
t
a
n
t
% Salmonella
% Ecoli
 
Figure 5. Percentage of calves that were MDR for both Salmonella and E.coli   28
DISCUSSION 
Samples from this study came from a larger study designed to assess the animal 
and herd-level incidence of salmonellosis among dairy cattle in the northeastern United 
States (Cripps et al., 2006; Ray, 2007). This study examined the patterns of antimicrobial 
resistance for E.coli and Salmonella enterica in 74 dairy calves.  
A high prevalence of antimicrobial resistance among both Salmonella and E.coli 
was observed in this study. Isolates tended to be resistant to similar antimicrobial agents, 
including AMP, CEF, CHL, FLO, NEO, OXY, SCH, SDI, and STH. The occurrence of 
MDR enteric bacteria could be related to local selection pressures from increased 
antimicrobial use for either prevention or treatment of diseases, such as salmonellosis. It 
is also possible that dissemination of highly resistant strains plays a role (Davies, 1999). 
Factors such as farm size, location, calves born in a building rather than outdoors, and 
rodent or bird control may have contributed to the occurrence of Salmonella within the 
herds (Warnick et al., 2001). The potential for gene transfer between the two strains of 
enteric bacteria could also explain the frequency of MDR that was observed in this study. 
It was not surprising that Salmonella and E.coli were mostly susceptible to APR, 
GEN, and ENR. Apramycin is approved only for use in the swine industry (although not 
approved, it is still sometimes used to treat calves) (Plumb, 2002) and resistance is rare 
among gram negative bacteria (Prescott, J.F., et.al., 2000). Although most isolates were 
susceptible to gentamicin, in vitro testing for gentamicin does not relate well to clinical 
efficacy. It should also be noted that gentamicin use in cattle is discouraged because of 
prolonged tissue residues. Enrofloxacin, a fluoroquinolone, is not approved for use in   29
dairy cattle and fluoroquinolone resistance is rare in enteric bacteria isolated from cattle 
(Plumb, 2002).  
Commensal enteric E.coli may play an important role of R factor transfer with 
other bacteria in animals. It is already known that Salmonella has mobile genetic 
elements containing several resistance genes (e.g. integrons or transposons) located on 
plasmids or integrated into the chromosome. These genetic elements have been found to 
play an important role in the transmission of resistance to multiple drugs between certain 
Salmonella serotypes (Ray, 2007). It is therefore a concern that E.coli may constitute a 
potential reservoir of resistance genes that could be transferred to pathogenic bacteria, 
such as Salmonella (Donaldson et al., 2006). Dairy calves typically have a relatively high 
percentage of resistant E.coli within 2 weeks after birth (Berge, 2005). In one previous 
study, resistance decreased after 2 weeks of age (Khachatryan, 2004). In contrast, in our 
study, resistance did not appear to decrease with age possibly because of isolates were 
from clinical cases.  Among the isolates in our study, most antimicrobial resistant isolates 
were resistant to five or more antimicrobial agents. Salmonella’s acquisition of new 
resistance, specifically from E.coli, could result in MDR strains being less responsive to 
treatment with antimicrobial drugs, resulting in larger outbreaks or more serious disease 
in people. 
Figure 4 suggests a relationship between Salmonella and E.coli, which tended to 
show similar trends for resistance to the same antimicrobial agents; however there were 
few statistically significant associations between E.coli and Salmonella resistance. In a 
previous molecular study, for individual antibiotics different genetic properties of R 
factors were found in Salmonella Typhimurium and E.coli species isolated from the same   30
calf. All R factors of S. Typhimurium were fi
-, whereas most of E.coli was fi
+ (Sato and 
Terakado, 1977). Another study observed drug-resistance patterns of Salmonella and 
E.coli strains isolated from the same sample to be the same even though the genetic 
properties of the R plasmids derived from E.coli were different from those of S. 
Typhimuirum (Ishiguro et. al., 1980). A more recent study (Mandal et. al., 2003) 
concluded that Salmonella enterica serovar Typhi’s acquired R-plasmid-encoded-
resistance from Escherichia coli. With the current study’s size and cross-sectional design, 
relatively infrequent transfer of resistant genes occurring over a longer time period can, 
therefore, not be ruled out. 
 
CONCLUSION / CLINCAL RELEVANCE 
Overall, E.coli isolates were more resistant than Salmonella. While there were 
some shared patterns of resistance between Salmonella and E.coli, Salmonella isolates 
were not more likely to be resistant to individual antibiotics if a calf had a resistant E.coli. 
Results suggest that selection pressure from recent exposure to drugs or interspecific gene 
transfer was not resulting in a strong association of resistance between the bacteria.   31
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APPENDICES 
 
Appendix 1. Antimicrobial Patterns for Salmonella and E.coli for Individual Calves (n=74)  
 
Age 
Group Accession  SubAcc  Age(in days)
SALMONELLA
 a
12345678901234
E.COLI
 a
12345678901234
70078.04 1  1  00000000000000 10010001100000
103538.04 1  1  00000000000000 00010001101111
120321.04 1  1  00000000000000 10110101110111
15728.05 2  1  10000100111110 10010001100111
108831.05 1  1  1_110100101110 0_010000101000
108831.05 3  1  1_110000101110 0_010001101000
93016.04 3  2  1_110101101110 10010001111111
121360.04 1  2  10010100111110 10110101110101
121387.04 3  2  10110101101110 10110101110110
121370.04 4  2  10110101101110 10010001111111
23345.05 1  2  1_110101101110 1_110101111110
52860.05 1  2  1_010001111110 1_110101111111
53682.05 2  2  1_010001111110 1_110101111111
82690.05 1  2  1_010001111110 1_110101111111
90199.05 1  2  1_110100101110 1_110101111111
88254.05 1  2  0_000000001100 1_010001111111
130793.05 3  2  1_110101101111 1_110000101111
130793.05 5  2  1_110101101111 1_110101111111
85275.04 4  3  10110101111110 10110101111110
15434.05 1  3  10110100111111 10110110111111
46245.05 1  3  1_100101101110 1_110101101110
130793.05 1  3  1_110101101111 1_110101111111
1
-
4
 
d
a
y
s
 
99293.05 1  4  0_000000001000 1_110100111111
24673.04 1  5  00000000000000 00010000110000
88465.04 1  5  10110100101110 10110111111111
68448.05 6  5  0_000000001100 1_110101101110
135032.04 4  5  10110101101110 10010111111111
131849.04 1  6  10110100111111 10110101111111
125225.04 2  7  10110101101110 10110011110110
25951.05 3  7  1_010101111110 1_010011111111
25951.05 3  7  1_010101111110 1_010011111111
102877.05 1  7  1_110001111111 1_110001111111
137768.04 1  7  00000000000000 10010001111111
137768.04 2  7  00000000000000 10010000110001
79914.05 1  7  1_010001111110 1_0_0_1______1
13273.05 14  8  10110101101110 10010001100110
13273.05 15  8  1_110101101110 1__1__011_1__0
26871.05 5  8  1_010101101110 1_010011111111
91667.04 1  8  00000000000000 10110101101111
112232.04 1  9  00000000000000 10110111111111
121190.04 1  9  10110101101110 10110011110111
5
-
1
0
 
d
a
y
s
 
26871.05 4  9  1_000100111110 1_110101111111  36
70988.04 1  10  00000000000000 10110111111111
21529.05 2  10  10110101101110 10110101111111
26871.05 3  10  1_010101111110 1_010001111111
32673.05 1  10  0_000000001100 1_010001101111
32354.05 1  10  1_010101101110 1_010001111111
55296.05 2  10  0_000000001100 1_110111111111
133476.04 3  10  1_110101101110 10010001111111
833.05 1  10  00000000000000 10010001101111
833.05 2  10  00000000000000 10010001101111
137192.04 1  10  00000000000000 10010001101111
90676.04 1  11  00010101101110 10010101111111
10799.05 4  11  10110111111110 11010011111111
10799.05 5  11  10110111111110 10111111110111
101139.05 1  11  1_110101101110 1_110111111111
103917.05 1  11  1_110101101110 1_110101101110
133476.04 4  11  10110101101110 10010101111111
135032.04 5  11  10110101100110 10010001111111
79193.04 2  12  0_000000001000 10110101111111
111866.05 1  12  1_010001111110 1_110101111111
126712.04 1  13  10110101101110 10110101100110
106861.04 2  14  10110101111110 10000001000111
126712.04 3  14  10110101101110 10110101100110
76286.04 1  16  00000000000000 10110101111111
110020.04 1  16  10110101111110 10010101110111
110783.04 1  17  10110101111110 10110101110111
126712.04 2  20  10110101101110 00010101101110
79193.04 1  21  00000000000000 10010001111111
101139.05 2  21  1_110101101110 1_110111111111
13273.05 13  27  1_110101101110 1__1__011_0__1
83084.04 6  40  00000000000000 10110101111111
83084.04 9  43  0_000000001000 00000000000000
1
1
-
4
4
 
d
a
y
s
 
83084.04 7  44  0_000000001000 10010001100000
a 1(AMP); 2(APR); 3(CEF); 4(CHL); 5(ENR); 6(FLO); 7(GEN); 8(NEO); 9(OXY); 0(SPE); 1(SCH); 2(SDI); 
3(STH); 4(TRI) 
0, Not Resistant; 1, Resistant; _, not tested 
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Appendix 2. Relationship of resistance for Salmonella and E .coli isolates 
 
AMP:   Salmonella    OXY:    Salmonella  
   0  1       0 1  
0 3 3     0 1 2   Ecoli 
1 21 47    
Ecoli 
1 22 49  
     7 4        7 4
            
APR:   Salmonella    SPE:    Salmonella  
   0  1       0 1  
0 73  0     0 21 3   Ecoli 
1 1 0    
Ecoli 
1 33 17  
     7 4        7 4
            
CEF:   Salmonella    SCH:    Salmonella  
   0  1       0 1  
0 21 15     0  4 16   Ecoli 
1 16 22    
Ecoli 
1 12 42  
     7 4        7 4
            
CHL:   Salmonella    SDI    Salmonella  
   0  1       0 1  
0 1 2     0 5 5   Ecoli 
1 25 46    
Ecoli 
1 14 50  
     7 4        7 4
            
ENR:   Salmonella    STH:    Salmonella  
   0  1       0 1  
0  73 0     0 5 6   Ecoli 
1 1 0    
Ecoli 
1 18 45  
     7 4        7 4
            
ERY:   Salmonella    TIA:    Salmonella  
   0  1       0 1  
0  14 0     0 0 3   Ecoli 
1 0  60    
Ecoli 
1 0 71  
     7 4        7 4
            
FLO:   Salmonella    TIL:    Salmonella  
   0  1       0 1  
0 16 19     0  0 3   Ecoli 
1 14 25    
Ecoli 
1 0 71  
     7 4        7 4
            
GEN:   Salmonella    TRI:    Salmonella  
   0  1       0 1  
0 58  0     0 18 0   Ecoli 
1 14  2    
Ecoli 
1 50 6  
     7 4        7 4  38
               
NEO:   Salmonella      MDR:    Salmonella  
   0  1          0 1  
0 6 2       0  48 19   Ecoli 
1 26 40      
Ecoli 
1 3 4  
    7 4         7 4
0, not resistant; 1, resistant 
 